Transphorm Inc.

NASDAQ: TGAN · Real-Time Price · USD
5.10
0.34 (7.14%)
At close: Jun 20, 2024, 10:00 PM

Transphorm Balance Sheet Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2023 Mar 31, 2022 Dec 31, 2020
Cash & Equivalents
15.53M 33.44M 14.69M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
715K 143K n/a
Other Long-Term Assets
726K 263K 291K
Receivables
4.4M 2.63M 844K
Inventory
8.41M 6.33M 1.63M
Other Current Assets
1.86M 2.47M 1.06M
Total Current Assets
30.69M 44.65M 18.23M
Property-Plant & Equipment
10.92M 1.8M 1.32M
Goodwill & Intangibles
1.4M 1.8M 2.38M
Total Long-Term Assets
13.76M 4M 4M
Total Assets
44.45M 48.65M 22.23M
Account Payables
7.89M 3.63M 3.18M
Deferred Revenue
-19.89M 308K 674K
Short-Term Debt
12.4M 180K 20.15M
Other Current Liabilities
21.53M 1.17M 2.68M
Total Current Liabilities
21.94M 5.29M 26.69M
Long-Term Debt
2.67M 12M 15.39M
Other Long-Term Liabilities
230K n/a n/a
Total Long-Term Liabilities
2.9M 12M 15.39M
Total Liabilities
24.84M 17.29M 42.08M
Total Debt
15.07M 12.18M 35.55M
Common Stock
6K 5K 4K
Retained Earnings
-209.24M -178.64M -161.82M
Comprehensive Income
-1.43M -1.2M -772K
Shareholders Equity
19.61M 31.36M -19.86M
Total Investments
715K 143K n/a